Keeping Track: Kybella, Ixinity, Raplixa Approved; Three 'Complete Responses' Surprise No One
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
GSK Gets New Start For Breo With FDA Approval In Asthma
FDA approved Breo Ellipta as a once-daily treatment for asthma, a new indication for a drug that has been on the market since October 2013 for COPD.
Ground Hog Day For Merck: FDA Again Cancels Sugammadex Advisory Committee Review
FDA is conducting additional inspections of the site of a hypersensitivity study the agency requested in 2008; concerns about the study derailed a committee review in 2013.
PTC’s Upstaza Takes Gene Therapy Straight To Brain (And US FDA); Translarna To Return Mid-Year
In a year full of regulatory milestones for the firm, PTC Therapeutics hopes to set some approval precedents – and basically hopes its candidates have an easier time of it than they have had before.